{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["bone remodelling", "complementary therapies", "herbal medicine", "osteoblast", "osteoclast"]], "SpaceFlightMission": [], "InvestigatorList": [], "OtherAbstract": [], "OtherID": [], "CitationSubset": ["IM"], "GeneralNote": [], "PMID": "29751644", "DateCompleted": {"Year": "2019", "Month": "01", "Day": "04"}, "DateRevised": {"Year": "2024", "Month": "03", "Day": "18"}, "Article": {"ArticleDate": [{"Year": "2018", "Month": "05", "Day": "11"}], "Language": ["eng"], "ELocationID": ["963", "10.3390/ijerph15050963"], "Journal": {"ISSN": "1660-4601", "JournalIssue": {"Volume": "15", "Issue": "5", "PubDate": {"Year": "2018", "Month": "May", "Day": "11"}}, "Title": "International journal of environmental research and public health", "ISOAbbreviation": "Int J Environ Res Public Health"}, "ArticleTitle": "Protective Effects of Selected Botanical Agents on Bone.", "Abstract": {"AbstractText": ["Osteoporosis is a serious health problem affecting more than 200 million elderly people worldwide. The early symptoms of this disease are hardly detectable. It causes progressive bone loss, which ultimately renders the patients susceptible to fractures. Osteoporosis must be prevented because the associated fragility fractures result in high morbidity, mortality, and healthcare costs. Many plants used in herbal medicine contain bioactive compounds possessing skeletal protective effects. This paper explores the anti-osteoporotic properties of selected herbal plants, including their actions on osteoblasts (bone forming cells), osteoclasts (bone resorbing cells), and bone remodelling. Some of the herbal plant families included in this review are Berberidaceae, Fabaceae, Arecaceae, Labiatae, Simaroubaceaea, and Myrsinaceae. Their active constituents, mechanisms of action, and pharmaceutical applications were discussed. The literature shows that very few herbal plants have undergone human clinical trials to evaluate their pharmacological effects on bone to date. Therefore, more intensive research should be performed on these plants to validate their anti-osteoporotic properties so that they can complement the currently available conventional drugs in the battle against osteoporosis."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras 56000, Wilayah Persekutuan Kuala Lumpur, Malaysia. jamesjamjolly@yahoo.com.my."}], "LastName": "Jolly", "ForeName": "James Jam", "Initials": "JJ"}, {"Identifier": ["0000-0001-6628-1552"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras 56000, Wilayah Persekutuan Kuala Lumpur, Malaysia. chinkokyong@ppukm.ukm.edu.my."}], "LastName": "Chin", "ForeName": "Kok-Yong", "Initials": "KY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biochemistry, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras 56000, Wilayah Persekutuan Kuala Lumpur, Malaysia. ekram.alias@ppukm.ukm.edu.my."}], "LastName": "Alias", "ForeName": "Ekram", "Initials": "E"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Physiology, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras 56000, Wilayah Persekutuan Kuala Lumpur, Malaysia. ckienhui@gmail.com."}], "LastName": "Chua", "ForeName": "Kien Hui", "Initials": "KH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology, Faculty of Medicine, Pusat Perubatan Universiti Kebangsaan Malaysia, Jalan Yaacob Latif, Bandar Tun Razak, Cheras 56000, Wilayah Persekutuan Kuala Lumpur, Malaysia. imasoel@ppukm.ukm.edu.my."}], "LastName": "Soelaiman", "ForeName": "Ima Nirwana", "Initials": "IN"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Int J Environ Res Public Health", "NlmUniqueID": "101238455", "ISSNLinking": "1660-4601"}, "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Aged"}, {"QualifierName": [], "DescriptorName": "Bone Resorption"}, {"QualifierName": ["drug effects"], "DescriptorName": "Bone and Bones"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["drug effects"], "DescriptorName": "Osteoblasts"}, {"QualifierName": ["drug effects"], "DescriptorName": "Osteoclasts"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Osteoporosis"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}], "CoiStatement": "The authors report no conflicts of interest in this work."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Lama A., Santoro A., Corrado B., Pirozzi C., Paciello O., Pagano T.B., Russo S., Calignano A., Mattace Raso G., Meli R. Extracorporeal shock waves alone or combined with raloxifene promote bone formation and suppress resorption in ovariectomized rats. PLoS ONE. 2017;12:e0171276. doi: 10.1371/journal.pone.0171276.", "ArticleIdList": ["10.1371/journal.pone.0171276", "PMC5291474", "28158228"]}, {"Citation": "Sucuoglu H., Koyuncu H. Distribution of male osteoporosis patients according to age, classification, and fracture. Istanb. Med. J. 2017;18:13\u201317. doi: 10.5152/imj.2016.26234.", "ArticleIdList": ["10.5152/imj.2016.26234"]}, {"Citation": "Poole K.E.S., Skingle L., Gee A.H., Turmezei T.D., Johannesdottir F., Blesic K., Rose C., Vindlacheruvu M., Donell S., Vaculik J., et al. Focal osteoporosis defects play a key role in hip fracture. Bone. 2017;94:124\u2013134. doi: 10.1016/j.bone.2016.10.020.", "ArticleIdList": ["10.1016/j.bone.2016.10.020", "PMC5135225", "27777119"]}, {"Citation": "Iseme R.A., Mcevoy M., Kelly B., Agnew L., Walker F.R., Attia J. Is osteoporosis an autoimmune mediated disorder? Bone Rep. 2017:121\u2013131. doi: 10.1016/j.bonr.2017.10.003.", "ArticleIdList": ["10.1016/j.bonr.2017.10.003", "PMC5671387", "29124082"]}, {"Citation": "Eastell R., Christiansen C., Grauer A., Kutilek S., Libanati C., McClung M.R., Reid I.R., Resch H., Siris E., Uebelhart D. Effects of denosumab on bone turnover markers in postmenopausal osteoporosis. J. Bone Miner. Res. 2011;26:530\u2013537. doi: 10.1002/jbmr.251.", "ArticleIdList": ["10.1002/jbmr.251", "20839290"]}, {"Citation": "Szulc P., Delmas P. Bone loss in elderly men: Increased endosteal bone loss and stable periosteal apposition. The prospective minos study. Osteoporos. Int. 2007;18:495\u2013503. doi: 10.1007/s00198-006-0254-3.", "ArticleIdList": ["10.1007/s00198-006-0254-3", "PMC1820756", "17253119"]}, {"Citation": "Misiorowski W. Osteoporosis in men. Prz. Menopauzalny. 2017;16:70\u201373. doi: 10.5114/pm.2017.68596.", "ArticleIdList": ["10.5114/pm.2017.68596", "PMC5509976", "28721134"]}, {"Citation": "Moreira-Marconi E., Dionello C.F., Morel D.S., S\u00e1-Caputo D.C., Souza-Gon\u00e7alves C.R., Paineiras-Domingos L.L., Guedes-Aguiar E.O., Marin P.J., del Pozo Cruz B., Bernardo-Filho M. Could whole body vibration exercises influence the risk factors for fractures in women with osteoporosis? Osteoporos. Sarcopenia. 2016;2:214\u2013220. doi: 10.1016/j.afos.2016.09.003.", "ArticleIdList": ["10.1016/j.afos.2016.09.003", "PMC6372741", "30775489"]}, {"Citation": "Rachner T.D., Khosla S., Hofbauer L.C. Osteoporosis: Now and the future. Lancet. 2011;377:1276\u20131287. doi: 10.1016/S0140-6736(10)62349-5.", "ArticleIdList": ["10.1016/S0140-6736(10)62349-5", "PMC3555696", "21450337"]}, {"Citation": "Orcel P., Funck-Brentano T. Medical management following an osteoporotic fracture. Orthop. Traumatol. Surg. Res. 2011;97:860\u2013869. doi: 10.1016/j.otsr.2011.10.002.", "ArticleIdList": ["10.1016/j.otsr.2011.10.002", "22119511"]}, {"Citation": "Khosla S., Hofbauer L.C. Osteoporosis treatment: Recent developments and ongoing challenges. Lancet Diabetes Endocrinol. 2017;5:898\u2013907. doi: 10.1016/S2213-8587(17)30188-2.", "ArticleIdList": ["10.1016/S2213-8587(17)30188-2", "PMC5798872", "28689769"]}, {"Citation": "Wu L., Ling Z., Feng X., Mao C., Xu Z. Herb medicines against osteoporosis: Active compounds & relevant biological mechanisms. Curr. Top. Med. Chem. 2017;17:1670\u20131691.", "ArticleIdList": ["27848901"]}, {"Citation": "Augustine M., Horwitz M.J. Parathyroid hormone and parathyroid hormone-related protein analogs as therapies for osteoporosis. Curr. Osteoporos. Rep. 2013;11:400\u2013406. doi: 10.1007/s11914-013-0171-2.", "ArticleIdList": ["10.1007/s11914-013-0171-2", "PMC3874264", "24078470"]}, {"Citation": "Reginster J.Y., Pelousse F., Bruyere O. Safety concerns with the long-term management of osteoporosis. Expert Opin. Drug Saf. 2013;12:507\u2013522. doi: 10.1517/14740338.2013.793669.", "ArticleIdList": ["10.1517/14740338.2013.793669", "23614635"]}, {"Citation": "Hough F.S., Brown S.L., Cassim B., Davey M.R., de Lange W., de Villiers T.J., Ellis G.C., Lipschitz S., Lukhele M., Pettifor J.M. The safety of osteoporosis medication. S. Afr. Med. J. 2014;104:279\u2013282. doi: 10.7196/SAMJ.7505.", "ArticleIdList": ["10.7196/SAMJ.7505", "25118550"]}, {"Citation": "Deal C. Potential new drug targets for osteoporosis. Nat. Rev. Rheumatol. 2009;5:20. doi: 10.1038/ncprheum0977.", "ArticleIdList": ["10.1038/ncprheum0977", "19098925"]}, {"Citation": "Kenakin T., Christopoulos A. Signalling bias in new drug discovery: Detection, quantification and therapeutic impact. Nat. Rev. Drug Discov. 2013;12:205. doi: 10.1038/nrd3954.", "ArticleIdList": ["10.1038/nrd3954", "23411724"]}, {"Citation": "Fouda A.-M., Youssef A.R. Antiosteoporotic activity of salvadora persica sticks extract in an estrogen deficient model of osteoporosis. Osteoporos. Sarcopenia. 2017;3:132\u2013137. doi: 10.1016/j.afos.2017.07.002.", "ArticleIdList": ["10.1016/j.afos.2017.07.002", "PMC6372776", "30775518"]}, {"Citation": "Zhang N.-D., Han T., Huang B.-K., Rahman K., Jiang Y.-P., Xu H.-T., Qin L.-P., Xin H.-L., Zhang Q.-Y., Li Y.-M. Traditional chinese medicine formulas for the treatment of osteoporosis: Implication for antiosteoporotic drug discovery. J. Ethnopharmacol. 2016;189:61\u201380. doi: 10.1016/j.jep.2016.05.025.", "ArticleIdList": ["10.1016/j.jep.2016.05.025", "27180315"]}, {"Citation": "Zhang L.L., Xu W., Xu Y.L., Chen X., Huang M., Lu J.J. Therapeutic potential of rhizoma alismatis: A review on ethnomedicinal application, phytochemistry, pharmacology, and toxicology. Ann. N. Y. Acad. Sci. 2017;1401:90\u2013101. doi: 10.1111/nyas.13381.", "ArticleIdList": ["10.1111/nyas.13381", "28662316"]}, {"Citation": "Wang L., He Y.J., Han T., Zhao L., Lv L., He Y.Q., Zhang Q.Y., Xin H.L. Metabolites of curculigoside in rats and their antiosteoporotic activities in osteoblastic mc3t3-e1 cells. Fitoterapia. 2017;117:109\u2013117. doi: 10.1016/j.fitote.2017.01.009.", "ArticleIdList": ["10.1016/j.fitote.2017.01.009", "28126417"]}, {"Citation": "Desai S., Babaria P., Nakarani M., Shah K., Paranjape A. Antiosteoporotic effect of hemidesmus indicus linn. On ovariectomised rats. J. Ethnopharmacol. 2017;199:1\u20138. doi: 10.1016/j.jep.2017.01.031.", "ArticleIdList": ["10.1016/j.jep.2017.01.031", "28119100"]}, {"Citation": "Ahmad N., Chillara R., Kushwaha P., Khedgikar V., Karvande A., Choudhary D., Adhikary S., Maurya R., Trivedi R. Evaluation of anti-osteoporotic activity of butanolic fraction from passiflora foetida in ovariectomy-induced bone loss in mice. Biomed. Pharmacother. 2017;88:804\u2013813. doi: 10.1016/j.biopha.2017.01.100.", "ArticleIdList": ["10.1016/j.biopha.2017.01.100", "28160755"]}, {"Citation": "Tasadduq R., Gordon J., Al-Ghanim K.A., Lian J.B., Van Wijnen A.J., Stein J.L., Stein G.S., Shakoori A.R. Ethanol extract of cissus quadrangularis enhances osteoblast differentiation and mineralization of murine pre-osteoblastic mc3t3-e1 cells. J. Cell. Physiol. 2017;232:540\u2013547. doi: 10.1002/jcp.25449.", "ArticleIdList": ["10.1002/jcp.25449", "PMC5115982", "27264191"]}, {"Citation": "Karvande A., Khedgikar V., Kushwaha P., Ahmad N., Kothari P., Verma A., Kumar P., Nagar G.K., Mishra P.R., Maurya R. Heartwood extract from dalbergia sissoo promotes fracture healing and its application in ovariectomy-induced osteoporotic rats. J. Pharm. Pharmacol. 2017;69:1381\u20131397. doi: 10.1111/jphp.12764.", "ArticleIdList": ["10.1111/jphp.12764", "28664619"]}, {"Citation": "Jia M., Nie Y., Cao D.-P., Xue Y.-Y., Wang J.-S., Zhao L., Rahman K., Zhang Q.-Y., Qin L.-P. Potential antiosteoporotic agents from plants: A comprehensive review. Evid.-Based Complement. Altern. Med. 2012;2012:364604. doi: 10.1155/2012/364604.", "ArticleIdList": ["10.1155/2012/364604", "PMC3551255", "23365596"]}, {"Citation": "Liu X.L., Li J.H., Yang Y.F., Zhu J.Y. Floral development of gymnospermium microrrhynchum (berberidaceae) and its systematic significance in the nandinoideae. Flora. 2017;228:10\u201316. doi: 10.1016/j.flora.2017.01.002.", "ArticleIdList": ["10.1016/j.flora.2017.01.002"]}, {"Citation": "Sheng M., Chen Q., Wang L., Tian X. Hybridization among epimedium (berberidaceae) species native to china. Sci. Hortic. 2011;128:342\u2013351. doi: 10.1016/j.scienta.2011.01.020.", "ArticleIdList": ["10.1016/j.scienta.2011.01.020"]}, {"Citation": "Indran I.R., Liang R.L.Z., Min T.E., Yong E.-L. Preclinical studies and clinical evaluation of compounds from the genus epimedium for osteoporosis and bone health. Pharmacol. Ther. 2016;162:188\u2013205. doi: 10.1016/j.pharmthera.2016.01.015.", "ArticleIdList": ["10.1016/j.pharmthera.2016.01.015", "26820757"]}, {"Citation": "Ma H., He X., Yang Y., Li M., Hao D., Jia Z. The genus epimedium: An ethnopharmacological and phytochemical review. J. Ethnopharmacol. 2011;134:519\u2013541. doi: 10.1016/j.jep.2011.01.001.", "ArticleIdList": ["10.1016/j.jep.2011.01.001", "21215308"]}, {"Citation": "Hsieh T.P., Sheu S.Y., Sun J.S., Chen M.H., Liu M.H. Icariin isolated from epimedium pubescens regulates osteoblasts anabolism through bmp-2, smad4, and cbfa1 expression. Phytomedicine. 2010;17:414\u2013423. doi: 10.1016/j.phymed.2009.08.007.", "ArticleIdList": ["10.1016/j.phymed.2009.08.007", "19747809"]}, {"Citation": "Tantry M.A., Dar J.A., Idris A., Akbar S., Shawl A.S. Acylated flavonol glycosides from epimedium elatum, a plant endemic to the western himalayas. Fitoterapia. 2012;83:665\u2013670. doi: 10.1016/j.fitote.2012.02.003.", "ArticleIdList": ["10.1016/j.fitote.2012.02.003", "22366553"]}, {"Citation": "Hidaka S., Okamoto Y., Miyazaki K., Uesugi T. Evaluation of a soybean product fujiflavone p40 as an antiosteoporotic agent in rats. Phytother. Res. 2003;17:112\u2013119. doi: 10.1002/ptr.1047.", "ArticleIdList": ["10.1002/ptr.1047", "12601671"]}, {"Citation": "Ye S.F., Saga I., Ichimura K., Nagai T., Shinoda M., Matsuzaki S. Coumestrol as well as isoflavones in soybean extract prevent bone resorption in ovariectomized rats. Endocr. Regul. 2003;37:145\u2013152.", "ArticleIdList": ["14986720"]}, {"Citation": "Chin K.Y., Ima-Nirwana S. Can soy prevent male osteoporosis? A review of the current evidence. Curr. Drug Targets. 2013;14:1632\u20131641. doi: 10.2174/1389450114666131216222612.", "ArticleIdList": ["10.2174/1389450114666131216222612", "24354587"]}, {"Citation": "Lambert M.N.T., Thybo C.B., Lykkeboe S., Rasmussen L.M., Frette X., Christensen L.P., Jeppesen P.B. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: A randomized controlled trial. Am. J. Clin. Nutr. 2017;106:909\u2013920. doi: 10.3945/ajcn.117.153353.", "ArticleIdList": ["10.3945/ajcn.117.153353", "28768651"]}, {"Citation": "Ricci E., Cipriani S., Chiaffarino F., Malvezzi M., Parazzini F. Soy isoflavones and bone mineral density in perimenopausal and postmenopausal western women: A systematic review and meta-analysis of randomized controlled trials. J. Womens Health (Larchmt) 2010;19:1609\u20131617. doi: 10.1089/jwh.2010.2021.", "ArticleIdList": ["10.1089/jwh.2010.2021", "20673147"]}, {"Citation": "Taku K., Melby M.K., Kurzer M.S., Mizuno S., Watanabe S., Ishimi Y. Effects of soy isoflavone supplements on bone turnover markers in menopausal women: Systematic review and meta-analysis of randomized controlled trials. Bone. 2010;47:413\u2013423. doi: 10.1016/j.bone.2010.05.001.", "ArticleIdList": ["10.1016/j.bone.2010.05.001", "20452475"]}, {"Citation": "Arcoraci V., Atteritano M., Squadrito F., D\u2019Anna R., Marini H., Santoro D., Minutoli L., Messina S., Altavilla D., Bitto A. Antiosteoporotic activity of genistein aglycone in postmenopausal women: Evidence from a post-hoc analysis of a multicenter randomized controlled trial. Nutrients. 2017;9:179. doi: 10.3390/nu9020179.", "ArticleIdList": ["10.3390/nu9020179", "PMC5331610", "28241420"]}, {"Citation": "Jin X., Sun J., Yu B., Wang Y., Sun W.J., Yang J., Huang S.H., Xie W.L. Daidzein stimulates osteogenesis facilitating proliferation, differentiation, and antiapoptosis in human osteoblast-like mg-63 cells via estrogen receptor\u2013dependent mek/erk and pi3k/akt activation. Nutr. Res. 2017;42:20\u201330. doi: 10.1016/j.nutres.2017.04.009.", "ArticleIdList": ["10.1016/j.nutres.2017.04.009", "28633868"]}, {"Citation": "Zhai Y., Li Y., Wang Y., Cui J., Feng K., Kong X., Chen L. Psoralidin, a prenylated coumestan, as a novel anti-osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts. Eur. J. Pharmacol. 2017;801:62\u201371. doi: 10.1016/j.ejphar.2017.03.001.", "ArticleIdList": ["10.1016/j.ejphar.2017.03.001", "28283388"]}, {"Citation": "Chopra B., Dhingra A.K., Dhar K.L. Psoralea corylifolia l. (buguchi)\u2014Folklore to modern evidence: Review. Fitoterapia. 2013;90:44\u201356. doi: 10.1016/j.fitote.2013.06.016.", "ArticleIdList": ["10.1016/j.fitote.2013.06.016", "23831482"]}, {"Citation": "Weng Z.-B., Gao Q.-Q., Wang F., Zhao G.-H., Yin F.-Z., Cai B.-C., Chen Z.-P., Li W.-D. Positive skeletal effect of two ingredients of Psoralea corylifolia L. On estrogen deficiency-induced osteoporosis and the possible mechanisms of action. Mol. Cell. Endocrinol. 2015;417:103\u2013113. doi: 10.1016/j.mce.2015.09.025.", "ArticleIdList": ["10.1016/j.mce.2015.09.025", "26419930"]}, {"Citation": "Tang D.-Z., Yang F., Yang Z., Huang J., Shi Q., Chen D., Wang Y.-J. Psoralen stimulates osteoblast differentiation through activation of bmp signaling. Biochem. Biophys. Res. Commun. 2011;405:256\u2013261. doi: 10.1016/j.bbrc.2011.01.021.", "ArticleIdList": ["10.1016/j.bbrc.2011.01.021", "PMC3060402", "21219873"]}, {"Citation": "Li F., Li Q., Huang X., Wang Y., Ge C., Qi Y., Guo W., Sun H. Psoralen stimulates osteoblast proliferation through the activation of nuclear factor-\u03bab-mitogen-activated protein kinase signaling. Exp. Ther. Med. 2017;14:2385\u20132391. doi: 10.3892/etm.2017.4771.", "ArticleIdList": ["10.3892/etm.2017.4771", "PMC5609190", "28962172"]}, {"Citation": "Sen C.K., Rink C., Khanna S., Palm o Chen R., Zhang Y., Dong L., Huang J., Hua S., Fu X. Current Persperctive in the Discovery of Anti-aging Agents from Natural Products. Int. J. Curr. Adv. Res. 2017;27:335\u2013404.", "ArticleIdList": ["PMC5655361", "28567542"]}, {"Citation": "Sen C.K., Rink C., Khanna S. Palm oil\u2013derived natural vitamin e \u03b1-tocotrienol in brain health and disease. J. Am. Coll. Nutr. 2010;29:314S\u2013323S. doi: 10.1080/07315724.2010.10719846.", "ArticleIdList": ["10.1080/07315724.2010.10719846", "PMC3065441", "20823491"]}, {"Citation": "Sundram K., Sambanthamurthi R., Tan Y.-A. Palm fruit chemistry and nutrition. Asia Pac. J. Clin. Nutr. 2003;12:355\u2013362.", "ArticleIdList": ["14506001"]}, {"Citation": "Reeves J., III, Weihrauch J.L. Composition of Foods. Fats and Oils, Raw-Processed-Prepared; Chigago, IL, USA.  [(accessed on 10 May 2018)];1979  Available online:  https://www.cabdirect.org/cabdirect/abstract/19811420761."}, {"Citation": "Mustapa A., Manan Z., Azizi C.M., Setianto W., Omar A.M. Extraction of \u03b2-carotenes from palm oil mesocarp using sub-critical r134a. Food Chem. 2011;125:262\u2013267. doi: 10.1016/j.foodchem.2010.08.042.", "ArticleIdList": ["10.1016/j.foodchem.2010.08.042"]}, {"Citation": "Poku K. Small-Scale Palm Oil Processing in Africa. Volume 148 Food & Agriculture Org.; Roma, Italy: 2002."}, {"Citation": "Peh H.Y., Tan W.D., Liao W., Wong W.F. Vitamin e therapy beyond cancer: Tocopherol versus tocotrienol. Pharmacol. Ther. 2016;162:152\u2013169. doi: 10.1016/j.pharmthera.2015.12.003.", "ArticleIdList": ["10.1016/j.pharmthera.2015.12.003", "26706242"]}, {"Citation": "Ahsan H., Ahad A., Iqbal J., Siddiqui W.A. Pharmacological potential of tocotrienols: A review. Nutr. Metab. 2014;11:52. doi: 10.1186/1743-7075-11-52.", "ArticleIdList": ["10.1186/1743-7075-11-52", "PMC4247006", "25435896"]}, {"Citation": "Zhao L., Fang X., Marshall M.R., Chung S. Regulation of obesity and metabolic complications by gamma and delta tocotrienols. Molecules. 2016;21:344. doi: 10.3390/molecules21030344.", "ArticleIdList": ["10.3390/molecules21030344", "PMC6274282", "26978344"]}, {"Citation": "Shen C.L., Klein A., Chin K.Y., Mo H., Tsai P., Yang R.S., Chyu M.C., Ima-Nirwana S. Tocotrienols for bone health: A translational approach. Ann. N. Y. Acad. Sci. 2017;1401:150\u2013165. doi: 10.1111/nyas.13449.", "ArticleIdList": ["10.1111/nyas.13449", "28891093"]}, {"Citation": "Ng M.H., Choo Y.M., Ma A.N., Chuah C.H., Hashim M.A. Separation of vitamin e (tocopherol, tocotrienol, and tocomonoenol) in palm oil. Lipids. 2004;39:1031\u20131035. doi: 10.1007/s11745-004-1327-y.", "ArticleIdList": ["10.1007/s11745-004-1327-y", "15691027"]}, {"Citation": "Frega N., Mozzon M., Bocci F. Identification and estimation of tocotrienols in the annatto lipid fraction by gas chromatography-mass spectrometry. J. Am. Oil Chem. Soc. 1998;75:1723\u20131727. doi: 10.1007/s11746-998-0323-1.", "ArticleIdList": ["10.1007/s11746-998-0323-1"]}, {"Citation": "Chin K.-Y., Ima-Nirwana S. The biological effects of tocotrienol on bone: A review on evidence from rodent models. Drug Des. Dev. Ther. 2015;9:2049. doi: 10.2147/DDDT.S79660.", "ArticleIdList": ["10.2147/DDDT.S79660", "PMC4396581", "25897211"]}, {"Citation": "Wong S.K., Chin K.-Y., Suhaimi F.H., Ahmad F., Ima-Nirwana S. The effects of palm tocotrienol on metabolic syndrome and bone loss in male rats induced by high-carbohydrate high-fat diet. J. Funct. Foods. 2018;44:246\u2013254. doi: 10.1016/j.jff.2018.03.022.", "ArticleIdList": ["10.1016/j.jff.2018.03.022"]}, {"Citation": "Ginaldi L., Di Benedetto M.C., De Martinis M. Osteoporosis, inflammation and ageing. Immun. Ageing. 2005;2:14. doi: 10.1186/1742-4933-2-14.", "ArticleIdList": ["10.1186/1742-4933-2-14", "PMC1308846", "16271143"]}, {"Citation": "Manolagas S.C. From estrogen-centric to aging and oxidative stress: A revised perspective of the pathogenesis of osteoporosis. Endocr. Rev. 2010;31:266\u2013300. doi: 10.1210/er.2009-0024.", "ArticleIdList": ["10.1210/er.2009-0024", "PMC3365845", "20051526"]}, {"Citation": "Fatokun A.A., Stone T.W., Smith R.A. Responses of differentiated mc3t3-e1 osteoblast-like cells to reactive oxygen species. Eur. J. Pharmacol. 2008;587:35\u201341. doi: 10.1016/j.ejphar.2008.03.024.", "ArticleIdList": ["10.1016/j.ejphar.2008.03.024", "18448093"]}, {"Citation": "Ha H., Kwak H.B., Lee S.W., Jin H.M., Kim H.-M., Kim H.-H., Lee Z.H. Reactive oxygen species mediate rank signaling in osteoclasts. Exp. Cell Res. 2004;301:119\u2013127. doi: 10.1016/j.yexcr.2004.07.035.", "ArticleIdList": ["10.1016/j.yexcr.2004.07.035", "15530848"]}, {"Citation": "McLean R.R. Proinflammatory cytokines and osteoporosis. Curr. Osteoporos. Rep. 2009;7:134\u2013139. doi: 10.1007/s11914-009-0023-2.", "ArticleIdList": ["10.1007/s11914-009-0023-2", "19968917"]}, {"Citation": "Hermizi H., Faizah O., Ima-Nirwana S., Nazrun S.A., Norazlina M. Beneficial effects of tocotrienol and tocopherol on bone histomorphometric parameters in sprague\u2013dawley male rats after nicotine cessation. Calcif. Tissue Int. 2009;84:65\u201374. doi: 10.1007/s00223-008-9190-x.", "ArticleIdList": ["10.1007/s00223-008-9190-x", "19020790"]}, {"Citation": "Aktifanus A.T., Shuid A.N., Rashid N.H.A., Ling T.H., Loong C.Y., Saat N.M., Muhammad N., Mohamed N., Soelaiman I.N. Comparison of the effects of tocotrienol and estrogen on the bone markers and dynamic changes in postmenopausal osteoporosis rat model. Asian J. Anim. Vet. Adv. 2012;7:225\u2013234."}, {"Citation": "Soelaiman I.N., Ming W., Abu Bakar R., Hashnan N.A., Mohd Ali H., Mohamed N., Muhammad N., Shuid A.N. Palm tocotrienol supplementation enhanced bone formation in oestrogen-deficient rats. Int. J. Endocrinol. 2012;2012:532862. doi: 10.1155/2012/532862.", "ArticleIdList": ["10.1155/2012/532862", "PMC3485551", "23150728"]}, {"Citation": "Norazlina M., Ima-Nirwana S., Gapor M., Khalid B. Palm vitamin e is comparable to \u03b1-tocopherol in maintaining bone mineral density in ovariectomised female rats. Exp. Clin. Endocrinol. Diabetes. 2000;108:305\u2013310. doi: 10.1055/s-2000-7758.", "ArticleIdList": ["10.1055/s-2000-7758", "10961363"]}, {"Citation": "Ima-Nirwana S., Kiftiah A., Zainal A., Norazlina M., Gapor M., Khalid B. Palm vitamin e prevents osteoporosis in orchidectomized growing male rats. Nat. Prod. Sci. 2000;6:155\u2013160."}, {"Citation": "Ima S.N., Fakhrurazi H. Palm vitamin eprotects bone against dexamethasone-induced osteoporosis in male rats. Med. J. Malaysia. 2002;57:136\u2013144.", "ArticleIdList": ["24326643"]}, {"Citation": "Chin K.-Y., Gengatharan D., Mohd Nasru F.S., Khairussam R.A., Ern S.L.H., Aminuddin S.A.W., Ima-Nirwana S. The effects of annatto tocotrienol on bone biomechanical strength and bone calcium content in an animal model of osteoporosis due to testosterone deficiency. Nutrients. 2016;8:808. doi: 10.3390/nu8120808.", "ArticleIdList": ["10.3390/nu8120808", "PMC5188463", "27983628"]}, {"Citation": "Mohamad N.-V., Ima-Nirwana S., Chin K.-Y. Effect of tocotrienol from bixa orellana (annatto) on bone microstructure, calcium content, and biomechanical strength in a model of male osteoporosis induced by buserelin. Drug Des. Dev. Ther. 2018;12:555. doi: 10.2147/DDDT.S158410.", "ArticleIdList": ["10.2147/DDDT.S158410", "PMC5859897", "29588572"]}, {"Citation": "Mohamad N.V., Soelaiman I.N., Chin K.Y. Effects of tocotrienol from bixa orellana (annatto) on bone histomorphometry in a male osteoporosis model induced by buserelin. Biomed. Pharmacother. 2018;103:453\u2013462. doi: 10.1016/j.biopha.2018.04.083.", "ArticleIdList": ["10.1016/j.biopha.2018.04.083", "29674281"]}, {"Citation": "Chin K.Y., Ima-Nirwana S. Effects of annatto-derived tocotrienol supplementation on osteoporosis induced by testosterone deficiency in rats. Clin. Interv. Aging. 2014;9:1247\u20131259. doi: 10.2147/CIA.S67016.", "ArticleIdList": ["10.2147/CIA.S67016", "PMC4128692", "25120355"]}, {"Citation": "Chin K.Y., Ima-Nirwana S. The effects of alpha-tocopherol on bone: A double-edged sword? Nutrients. 2014;6:1424\u20131441. doi: 10.3390/nu6041424.", "ArticleIdList": ["10.3390/nu6041424", "PMC4011043", "24727433"]}, {"Citation": "Guralp O. Effects of vitamin e on bone remodeling in perimenopausal women: Mini review. Maturitas. 2014;79:476\u2013480. doi: 10.1016/j.maturitas.2014.08.012.", "ArticleIdList": ["10.1016/j.maturitas.2014.08.012", "25248856"]}, {"Citation": "Shen C.-L., Yang S., Tomison M.D., Romero A.W., Felton C.K., Mo H. Tocotrienol supplementation suppressed bone resorption and oxidative stress in postmenopausal osteopenic women: A 12-week randomized double-blinded placebo-controlled trial. Osteoporos. Int. 2018;29:881\u2013891. doi: 10.1007/s00198-017-4356-x.", "ArticleIdList": ["10.1007/s00198-017-4356-x", "29330573"]}, {"Citation": "Li X., Xu X., Wang J., Yu H., Wang X., Yang H., Xu H., Tang S., Li Y., Yang L. A system-level investigation into the mechanisms of chinese traditional medicine: Compound danshen formula for cardiovascular disease treatment. PLoS ONE. 2012;7:e43918. doi: 10.1371/journal.pone.0043918.", "ArticleIdList": ["10.1371/journal.pone.0043918", "PMC3433480", "22962593"]}, {"Citation": "Wu W.-Y., Wang Y.-P. Pharmacological actions and therapeutic applications of salvia miltiorrhiza depside salt and its active components. Acta Pharmacol. Sin. 2012;33:1119. doi: 10.1038/aps.2012.126.", "ArticleIdList": ["10.1038/aps.2012.126", "PMC4003110", "22941285"]}, {"Citation": "Guo Y., Li Y., Xue L., Severino R.P., Gao S., Niu J., Qin L.-P., Zhang D., Br\u00f6mme D. Salvia miltiorrhiza: An ancient chinese herbal medicine as a source for anti-osteoporotic drugs. J. Ethnopharmacol. 2014;155:1401\u20131416. doi: 10.1016/j.jep.2014.07.058.", "ArticleIdList": ["10.1016/j.jep.2014.07.058", "25109459"]}, {"Citation": "Baricevic D., Bartol T.V. Pharmacology 11. The biological/pharmacological activity of the salvia genus. In: Kintzios S.E., editor. The Genus Salvia. Harwood Academic Publishers; Amsterdam, The Netherland: 2000. pp. 143\u2013184."}, {"Citation": "Kim H.-K., Woo E.-R., Lee H.-W., Park H.-R., Kim H.-N., Jung Y.-K., Choi J.-Y., Chae S.-W., Kim H.-R., Chae H.-J. The correlation of salvia miltiorrhiza extract\u2013induced regulation of osteoclastogenesis with the amount of components tanshinone i, tanshinone iia, cryptotanshinone, and dihydrotanshinone. Immunopharmacol. Immunotoxicol. 2008;30:347\u2013364. doi: 10.1080/08923970801949133.", "ArticleIdList": ["10.1080/08923970801949133", "18569089"]}, {"Citation": "Lee S.-Y., Choi D.-Y., Woo E.-R. Inhibition of osteoclast differentiation by tanshinones from the root ofsalvia miltiorrhiza bunge. Arch. Pharm. Res. 2005;28:909\u2013913. doi: 10.1007/BF02973876.", "ArticleIdList": ["10.1007/BF02973876", "16178416"]}, {"Citation": "Kwak H.B., Yang D., Ha H., Lee J.-H., Kim H.-N., Woo E.-R., Lee S., Kim H.-H., Lee Z.H. Tanshinone iia inhibits osteoclast differentiation through down-regulation of c-fos and nfatc1. Exp. Mol. Med. 2006;38:256. doi: 10.1038/emm.2006.31.", "ArticleIdList": ["10.1038/emm.2006.31", "16819284"]}, {"Citation": "Cui L., Liu Y.-Y., Wu T., Ai C.-M., Chen H.-Q. Osteogenic effects of d (+) \u03b2-3, 4-dihydroxyphenyl lactic acid (salvianic acid a, saa) on osteoblasts and bone marrow stromal cells of intact and prednisone-treated rats. Acta Pharmacol. Sin. 2009;30:321. doi: 10.1038/aps.2009.9.", "ArticleIdList": ["10.1038/aps.2009.9", "PMC4002398", "19262556"]}, {"Citation": "Cui L., Li T., Liu Y., Zhou L., Li P., Xu B., Huang L., Chen Y., Liu Y., Tian X. Salvianolic acid b prevents bone loss in prednisone-treated rats through stimulation of osteogenesis and bone marrow angiogenesis. PLoS ONE. 2012;7:e34647. doi: 10.1371/journal.pone.0034647.", "ArticleIdList": ["10.1371/journal.pone.0034647", "PMC3321026", "22493705"]}, {"Citation": "Thu H.E., Mohamed I.N., Hussain Z., Jayusman P.A., Shuid A.N. Eurycoma longifolia as a potential adoptogen of male sexual health: A systematic review on clinical studies. Chin. J. Nat. Med. 2017;15:71\u201380. doi: 10.1016/S1875-5364(17)30010-9.", "ArticleIdList": ["10.1016/S1875-5364(17)30010-9", "28259255"]}, {"Citation": "Edwards S.E., da Costa Rocha I., Williamson E.M., Heinrich M. Phytopharmacy: An Evidence-Based Guide to Herbal Medicinal Products. John Wiley & Sons; Hoboken, NJ, USA: 2015. Tongkat ali eurycoma longifolia jack; p. 375."}, {"Citation": "Faisal G.G., Zakaria S.M., Najmuldeen G.F., Al-Ani I.M. Antifungal activity of eurycoma longifolia jack (tongkat ali) root extract. J. Int. Dent. Med. Res. 2016;9:70\u201374."}, {"Citation": "Thu H.E., Mohamed I.N., Hussain Z., Shuid A.N. Eurycoma longifolia as a potential alternative to testosterone for the treatment of osteoporosis: Exploring time-mannered proliferative, differentiative and morphogenic modulation in osteoblasts. J. Ethnopharmacol. 2017;195:143\u2013158. doi: 10.1016/j.jep.2016.10.085.", "ArticleIdList": ["10.1016/j.jep.2016.10.085", "27818256"]}, {"Citation": "Low B.-S., Choi S.-B., Abdul Wahab H., Kumar Das P., Chan K.-L. Eurycomanone, the major quassinoid in eurycoma longifolia root extract increases spermatogenesis by inhibiting the activity of phosphodiesterase and aromatase in steroidogenesis. J. Ethnopharmacol. 2013;149:201\u2013207. doi: 10.1016/j.jep.2013.06.023.", "ArticleIdList": ["10.1016/j.jep.2013.06.023", "23810842"]}, {"Citation": "Chin K.-Y., Ima-Nirwana S. Sex steroids and bone health status in men. Int. J. Endocrinol. 2012;2012:7. doi: 10.1155/2012/208719.", "ArticleIdList": ["10.1155/2012/208719", "PMC3488403", "23150727"]}, {"Citation": "Mohamad N.-V., Soelaiman I.-N., Chin K.-Y. A concise review of testosterone and bone health. Clin. Interv. Aging. 2016;11:1317. doi: 10.2147/CIA.S115472.", "ArticleIdList": ["10.2147/CIA.S115472", "PMC5036835", "27703340"]}, {"Citation": "Huber D.M., Bendixen A.C., Pathrose P., Srivastava S., Dienger K.M., Shevde N.K., Pike J.W. Androgens suppress osteoclast formation induced by rankl and macrophage-colony stimulating factor. Endocrinology. 2001;142:3800\u20133808. doi: 10.1210/endo.142.9.8402.", "ArticleIdList": ["10.1210/endo.142.9.8402", "11517156"]}, {"Citation": "Chin K.Y., Ima-Nirwana S. The effects of orchidectomy and supraphysiological testosterone administration on trabecular bone structure and gene expression in rats. Aging Male. 2015;18:60\u201366. doi: 10.3109/13685538.2014.954995.", "ArticleIdList": ["10.3109/13685538.2014.954995", "25166624"]}, {"Citation": "Corona G., Sforza A., Maggi M. Testosterone replacement therapy: Long-term safety and efficacy. World J. Men's Health. 2017;35:65\u201376. doi: 10.5534/wjmh.2017.35.2.65.", "ArticleIdList": ["10.5534/wjmh.2017.35.2.65", "PMC5583373", "28497912"]}, {"Citation": "Shuid A.N., Ping L.L., Muhammad N., Mohamed N., Soelaiman I.N. The effects of Labisia pumila var. Alata on bone markers and bone calcium in a rat model of post-menopausal osteoporosis. J. Ethnopharmacol. 2011;133:538\u2013542. doi: 10.1016/j.jep.2010.10.033.", "ArticleIdList": ["10.1016/j.jep.2010.10.033", "20971181"]}, {"Citation": "Fathilah S.N., Nazrun Shuid A., Mohamed N., Muhammad N., Nirwana Soelaiman I. Labisia pumila protects the bone of estrogen-deficient rat model: A histomorphometric study. J. Ethnopharmacol. 2012;142:294\u2013299. doi: 10.1016/j.jep.2012.04.029.", "ArticleIdList": ["10.1016/j.jep.2012.04.029", "22542643"]}, {"Citation": "Nadia M., Nazrun A., Norazlina M., Isa N., Norliza M., Ima Nirwana S. The anti-inflammatory, phytoestrogenic, and antioxidative role of Labisia pumila in prevention of postmenopausal osteoporosis. Adv. Pharmacol. Sci. 2012;2012:706905.", "ArticleIdList": ["PMC3353141", "22611381"]}, {"Citation": "Mohd Effendy N., Abdullah S., Yunoh M.F., Shuid A.N. Time and dose-dependent effects of Labisia pumila on the bone strength of postmenopausal osteoporosis rat model. BMC Complement. Altern. Med. 2015;15:58. doi: 10.1186/s12906-015-0567-x.", "ArticleIdList": ["10.1186/s12906-015-0567-x", "PMC4364645", "25887391"]}, {"Citation": "Fathilah S.N., Mohamed N., Muhammad N., Mohamed I.N., Soelaiman I.N., Shuid A.N. Labisia pumila regulates bone-related genes expressions in postmenopausal osteoporosis model. BMC Complement. Altern. Med. 2013;13:217. doi: 10.1186/1472-6882-13-217.", "ArticleIdList": ["10.1186/1472-6882-13-217", "PMC3847139", "24007208"]}, {"Citation": "Effendy N.M., Shuid A.N. Time and dose-dependent effects of Labisia pumila on bone oxidative status of postmenopausal osteoporosis rat model. Nutrients. 2014;6:3288\u20133302. doi: 10.3390/nu6083288.", "ArticleIdList": ["10.3390/nu6083288", "PMC4145309", "25195641"]}]}], "History": [{"Year": "2018", "Month": "4", "Day": "12"}, {"Year": "2018", "Month": "4", "Day": "29"}, {"Year": "2018", "Month": "5", "Day": "8"}, {"Year": "2018", "Month": "5", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2019", "Month": "1", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2018", "Month": "5", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["29751644", "PMC5982002", "10.3390/ijerph15050963", "ijerph15050963"]}}]}